Ipilimumab, Maraviroc and Nivolumab in Advanced Metastatic Colorectal and Pancreatic Cancer the LUMINESCENCE Trial
Ontology highlight
ABSTRACT: The study will be conducted in compliance with Good Clinical Practices (ICH-GCP) and the Declaration of Helsinki, and in accordance with applicable legal and regulatory requirements, including archiving of essential documents.
DISEASE(S): Pancreatic Cancer Metastatic,Colorectal Cancer Metastatic,Pancreatic Neoplasms,Neoplasms
PROVIDER: 2364813 | ecrin-mdr-crc |
REPOSITORIES: ECRIN MDR
ACCESS DATA